Validation of a Finger Prick–Based Capillary Blood Self-Sampling Technique for Monitoring Infliximab, Vedolizumab, and CRP Concentrations in Patients With IBD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Inflammatory Bowel Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical Validation of a Capillary Blood Home-Based Self-Sampling Technique for Monitoring of Infliximab, Vedolizumab, and C-Reactive Protein Concentrations in Patients With Inflammatory Bowel Disease
Inflamm. Bowel Dis. 2024 Mar 01;30(3)325-335, AT Otten, HH van der Meulen, M Steenhuis, FC Loeff, DJ Touw, JGW Kosterink, HW Frijlink, T Rispens, G Dijkstra, MC Visschedijk, AR BourgonjeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.